Search

• Written by: E. Friedman ×
• Person: R. Bruchim ×
• Clear filters

1 result for “Reaction Department”

1. Medical study · Medical research · 2021

   Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant

   …None of the three available tumors showed an allelic loss, there was no discernable effect on alternative splicing based on reverse-transcription polymerase chain reaction, and there was no decrease or loss of somatic protein expression…